Jet Solar Limited (BOM:538794)
20.30
+0.17 (0.84%)
At close: Aug 6, 2025
Sage Therapeutics Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 0.48 | 0.73 | 3.76 | 2.2 | 5.28 | Upgrade |
Short-Term Investments | 104.4 | - | - | - | - | Upgrade |
Cash & Short-Term Investments | 104.88 | 0.73 | 3.76 | 2.2 | 5.28 | Upgrade |
Cash Growth | 14273.43% | -80.59% | 71.18% | -58.42% | 76.16% | Upgrade |
Accounts Receivable | 5.25 | 7.18 | 6.86 | 3.48 | 6.42 | Upgrade |
Other Receivables | - | 14.31 | 13.05 | 13.3 | 11.87 | Upgrade |
Receivables | 100.59 | 21.49 | 19.92 | 16.78 | 18.29 | Upgrade |
Inventory | 17.97 | 21.71 | 22.29 | 19.74 | 18.51 | Upgrade |
Other Current Assets | 2.1 | 27.18 | 27.21 | 27.21 | 36.2 | Upgrade |
Total Current Assets | 225.54 | 71.11 | 73.18 | 65.92 | 78.28 | Upgrade |
Property, Plant & Equipment | 0.75 | 0.81 | 0.88 | 0.96 | 1.05 | Upgrade |
Long-Term Deferred Tax Assets | 0.18 | 0.18 | 0.18 | 0.18 | 0.18 | Upgrade |
Other Long-Term Assets | 0.17 | 0.17 | 0.17 | 0.17 | 0.13 | Upgrade |
Total Assets | 226.64 | 72.27 | 74.41 | 67.23 | 79.64 | Upgrade |
Accounts Payable | 0.85 | 0.36 | 1.07 | 0.42 | 0.48 | Upgrade |
Accrued Expenses | - | 6.98 | 5.64 | 3.37 | 3.47 | Upgrade |
Short-Term Debt | 4.28 | 4.44 | 6.86 | 3.79 | 18.04 | Upgrade |
Current Unearned Revenue | - | 0.22 | 1.3 | 1.35 | 0.4 | Upgrade |
Other Current Liabilities | 42.87 | 3.69 | 3.54 | 2.86 | 2.23 | Upgrade |
Total Current Liabilities | 47.99 | 15.68 | 18.41 | 11.8 | 24.61 | Upgrade |
Total Liabilities | 47.99 | 15.68 | 18.41 | 11.8 | 24.61 | Upgrade |
Common Stock | 100.52 | 41.92 | 20.96 | 20.96 | 20.96 | Upgrade |
Additional Paid-In Capital | - | 6.09 | 27.05 | 27.05 | 27.05 | Upgrade |
Retained Earnings | - | 8.58 | 7.99 | 7.43 | 7.01 | Upgrade |
Comprehensive Income & Other | 78.13 | - | - | - | - | Upgrade |
Shareholders' Equity | 178.65 | 56.59 | 55.99 | 55.43 | 55.02 | Upgrade |
Total Liabilities & Equity | 226.64 | 72.27 | 74.41 | 67.23 | 79.64 | Upgrade |
Total Debt | 4.28 | 4.44 | 6.86 | 3.79 | 18.04 | Upgrade |
Net Cash (Debt) | 100.6 | -3.71 | -3.1 | -1.6 | -12.75 | Upgrade |
Net Cash Per Share | 9.96 | -0.88 | -0.74 | -0.38 | -3.04 | Upgrade |
Filing Date Shares Outstanding | 13.59 | 6.5 | 4.19 | 4.19 | 4.19 | Upgrade |
Total Common Shares Outstanding | 13.59 | 4.19 | 4.19 | 4.19 | 4.19 | Upgrade |
Working Capital | 177.55 | 55.43 | 54.76 | 54.12 | 53.67 | Upgrade |
Book Value Per Share | 13.14 | 13.50 | 13.36 | 13.22 | 13.13 | Upgrade |
Tangible Book Value | 178.65 | 56.59 | 55.99 | 55.43 | 55.02 | Upgrade |
Tangible Book Value Per Share | 13.14 | 13.50 | 13.36 | 13.22 | 13.13 | Upgrade |
Buildings | - | 1.77 | 1.77 | 1.77 | 1.77 | Upgrade |
Machinery | - | 1.47 | 1.47 | 1.47 | 1.47 | Upgrade |
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.